To evaluate the anti-tumor efficacy of adjuvants in promoting CD8+ T cell-mediated tumor elimination, we utilized an OVA-expressing E.G7 tumor model in C57BL/6 mice. The gene discussed is CD8A; the disease is neoplasm.